Augmentation and impulsivity in restless legs syndrome patients
A complex interaction
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Impulse control disorders (ICDs), such as gambling disorder, compulsive sexual behavior, compulsive shopping, binge eating, and punding, are potentially devastating side effects of dopaminergic medication. There is an estimated prevalence of 14% in dopamine replacement therapy (DRT)–treated Parkinson disease (PD).1 Risk factors for ICDs in PD include younger age at disease onset, a history of alcohol or illicit substance abuse, smoking, and novelty-seeking personality traits.1,2 The use of DRT may be the greatest risk factor for the development of ICDs in PD, with dopamine agonist treatment associated with a 3.5-fold increased risk, although the effect was not dose-dependent.1 In patients with restless legs syndrome (RLS) without PD, augmentation and ICDs are increasingly recognized as serious side effects of DRT.
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 36
- © 2016 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Victoria Leavitt and Dr. Laura Hancock
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Augmentation and impulsive behaviors in restless legs syndromeCoexistence or association?Beatrice Heim, Atbin Djamshidian, Anna Heidbreder et al.Neurology, June 03, 2016 -
Clinical and Ethical Challenges
Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson diseaseHoward D. Weiss, Laura Marsh et al.Neurology: Clinical Practice, December 10, 2012 -
Article
Longitudinal analysis of impulse control disorders in Parkinson diseaseJean-Christophe Corvol, Fanny Artaud, Florence Cormier-Dequaire et al.Neurology, June 20, 2018 -
Views & Reviews
Association between restless legs syndrome and other movement disordersHortensia Alonso-Navarro, Elena García-Martín, José A.G. Agúndez et al.Neurology, April 19, 2019